ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 232 filers reported holding ACADIA PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.85 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,752 | +74.0% | 324 | +100.0% | 0.00% | – |
| Q2 2023 | $3,880 | +27.3% | 162 | 0.0% | 0.00% | – |
| Q1 2023 | $3,049 | +18.2% | 162 | 0.0% | 0.00% | – |
| Q4 2022 | $2,579 | -35.5% | 162 | -36.2% | 0.00% | – |
| Q3 2022 | $4,000 | +100.0% | 254 | +46.8% | 0.00% | – |
| Q2 2022 | $2,000 | -83.3% | 173 | -65.0% | 0.00% | – |
| Q1 2022 | $12,000 | -62.5% | 494 | -63.8% | 0.00% | -100.0% |
| Q4 2021 | $32,000 | +146.2% | 1,365 | +74.8% | 0.00% | 0.0% |
| Q3 2021 | $13,000 | +62.5% | 781 | +144.1% | 0.00% | – |
| Q2 2021 | $8,000 | +14.3% | 320 | +15.9% | 0.00% | – |
| Q1 2021 | $7,000 | -30.0% | 276 | +52.5% | 0.00% | -100.0% |
| Q4 2020 | $10,000 | +42.9% | 181 | +1.7% | 0.00% | – |
| Q3 2020 | $7,000 | 0.0% | 178 | +9.9% | 0.00% | – |
| Q2 2020 | $7,000 | +16.7% | 162 | 0.0% | 0.00% | – |
| Q1 2020 | $6,000 | -14.3% | 162 | 0.0% | 0.00% | -100.0% |
| Q4 2019 | $7,000 | +16.7% | 162 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $6,000 | +50.0% | 162 | 0.0% | 0.00% | – |
| Q2 2019 | $4,000 | 0.0% | 162 | 0.0% | 0.00% | – |
| Q1 2019 | $4,000 | +100.0% | 162 | 0.0% | 0.00% | – |
| Q4 2018 | $2,000 | -33.3% | 162 | 0.0% | 0.00% | – |
| Q3 2018 | $3,000 | – | 162 | +390.9% | 0.00% | – |
| Q2 2018 | $0 | -100.0% | 33 | -83.7% | 0.00% | -100.0% |
| Q1 2018 | $5,000 | 0.0% | 203 | +19.4% | 0.00% | 0.0% |
| Q4 2017 | $5,000 | 0.0% | 170 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $5,000 | 0.0% | 170 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $5,000 | -58.3% | 170 | -56.4% | 0.00% | 0.0% |
| Q1 2017 | $12,000 | +140.0% | 390 | +129.4% | 0.00% | 0.0% |
| Q4 2016 | $5,000 | – | 170 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fairmount Funds Management LLC | 432,317 | $11,154,000 | 4.70% |
| Baker Brothers Advisors | 41,910,704 | $1,081,296,000 | 4.69% |
| Palo Alto Investors LP | 2,337,877 | $60,317,000 | 3.44% |
| Birchview Capital, LP | 177,000 | $4,567,000 | 2.71% |
| Longitude (Cayman) Ltd. | 188,000 | $4,850,000 | 1.86% |
| GREAT POINT PARTNERS LLC | 311,217 | $8,029,000 | 1.66% |
| Avoro Capital Advisors LLC | 2,500,000 | $64,500,000 | 1.11% |
| PFM Health Sciences, LP | 1,302,129 | $33,595,000 | 1.03% |
| HealthCor Management, L.P. | 900,490 | $23,233,000 | 0.82% |
| Eversept Partners, LP | 420,000 | $10,836,000 | 0.82% |